Euroopa Liit - eesti - EMA (European Medicines Agency)

pfizer europe ma eeig - anidulafungiin - candidiasis - antimükoosid süsteemseks kasutamiseks - ravi invasiivse kandidoosi täiskasvanute ja laste patsientidel vanuses 1 kuu kuni < 18 aastat.

Euroopa Liit - eesti - EMA (European Medicines Agency)

pfizer europe ma eeig  - abrocitinib - dermatiit, atoopiline - muud dermatoloogilised preparaadid - cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.

Euroopa Liit - eesti - EMA (European Medicines Agency)

pfizer europe ma eeig  - voxelotor - anemia; anemia, hemolytic; anemia, sickle cell - other hematological agents - oxbryta is indicated for the treatment of haemolytic anaemia due to sickle cell disease (scd) in adults and paediatric patients 12 years of age and older as monotherapy or in combination with hydroxycarbamide.

Euroopa Liit - eesti - EMA (European Medicines Agency)

pfizer europe ma eeig - krizotiniib - kartsinoom, mitteväikerakk-kopsu - antineoplastilised ained - xalkori as monotherapy is indicated for:the first‑line treatment of adults with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with previously treated anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with ros1‑positive advanced non‑small cell lung cancer (nsclc)the treatment of paediatric patients (age ≥6 to.

Eesti - eesti - Ravimiamet

alembic pharmaceuticals europe limited - olmesartaanmedoksomiil+hüdroklorotiasiid - õhukese polümeerikattega tablett - 40mg+12,5mg 30tk; 40mg+12,5mg 90tk; 40mg+12,5mg 84tk; 40mg+12,5mg 20tk; 40mg+12,5mg 28tk; 40mg+12,5mg 56tk

Eesti - eesti - Ravimiamet

alembic pharmaceuticals europe limited - olmesartaanmedoksomiil+hüdroklorotiasiid - õhukese polümeerikattega tablett - 40mg+25mg 20tk; 40mg+25mg 14tk; 40mg+25mg 30tk; 40mg+25mg 56tk; 40mg+25mg 84tk; 40mg+25mg 90tk

Eesti - eesti - Ravimiamet

alembic pharmaceuticals europe limited - olmesartaanmedoksomiil+hüdroklorotiasiid - õhukese polümeerikattega tablett - 20mg+12,5mg 56tk; 20mg+12,5mg 84tk; 20mg+12,5mg 14tk; 20mg+12,5mg 20tk; 20mg+12,5mg 30tk; 20mg+12,5mg 28tk

Eesti - eesti - Ravimiamet

alembic pharmaceuticals europe limited - olmesartaanmedoksomiil+hüdroklorotiasiid - õhukese polümeerikattega tablett - 20mg+25mg 28tk; 20mg+25mg 90tk; 20mg+25mg 14tk

Eesti - eesti - Ravimiamet

alembic pharmaceuticals europe limited - telmisartaan+amlodipiin - tablett - 80mg+10mg 98tk; 80mg+10mg 14tk; 80mg+10mg 7tk; 80mg+10mg 90tk; 80mg+10mg 10tk; 80mg+10mg 30tk

Eesti - eesti - Ravimiamet

alembic pharmaceuticals europe limited - olmesartaanmedoksomiil+amlodipiin+hüdroklorotiasiid - õhukese polümeerikattega tablett - 40mg+5mg+12,5mg 98tk; 40mg+5mg+12,5mg 30tk; 40mg+5mg+12,5mg 28tk; 40mg+5mg+12,5mg 90tk; 40mg+5mg+12,5mg 84tk; 40mg+5mg+12,5mg 56tk; 40mg+5mg+12,5mg 300tk; 40mg+5mg+12,5mg 280tk; 40mg+5mg+12,5mg 14tk